What is BRTX's dilution risk score?

BRTX currently has a DilutionScore of 74/100, indicating high dilution risk. DilutionWatch monitors BRTX SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for BRTX?

DilutionWatch tracks 25 SEC filing types for BRTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BRTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BRTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BRTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BRTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BRTX Stock Dilution Tracker: Score 74/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

85

💰 Cash Runway

85

📊 Float Risk

15

⚠️ Warrant Exposure

50

🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️

Warning

High probability of dilution event

67%

💰 Capital Raise 73%

• Low cash runway: 6 months remaining

• Active shelf registration ($10M, 82% of market cap)

🔄 Reverse Split 70%

• 50-day avg $0.25 below $1 exchange minimum

• Only 6 months cash — financial pressure

📉 Score Deterioration 50%

• Score rose 55 points recently (worsening)

• Score in HIGH risk zone (74/100)

🔔 Track BRTX — Get forecast alerts →

💹 Market Data

Market Cap$12.18M

Shares Outstanding25.48M

Float24.18M

Cash$2.95M

Debt$42.3K

Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 677.1K shares

#1 Citadel Advisors Llc 238.6K shares

#2 Geode Capital Management, LLC 223.1K shares

#3 UBS Group AG 99.8K shares

+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest368.7K

Days to Cover1.0

% of Float1.5%

FINRA data as of May 15, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025

xbrl XBRL CONVERTIBLE Dec 31, 2021

424B3 ATM Apr 30, 2026

EFFECT EFFECT Apr 28, 2026

13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026

Full SEC filing analysis available with free account →

📰 Recent News

Sector Update: Healthcare Stocks Decline Tuesday Afternoon MT Newswires · May 26

What Makes Biorestorative Therapies (BRTX) a New Buy Stock Zacks · May 15

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates Zacks · May 14

🔬 More Research for BRTX

📊 BRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BRTX Signal Convergence & Dark Pool Activity — StonkWhisper 📄 BRTX Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

BRTX — BioRestorative Therapies, Inc. Dilution Risk Tracker